BusinessBioLargo's Medical Subsidiary Files 510(k) with FDA for its Novel Wound Care TechnologyBy Nasdaq OMXSep 28, 2017, 1:12 PM UTC
BusinessBioLargo Acquires World-Class Engineering Team to Form a New Engineering Services Subsidiary and Enters into Common Stock Purchase Agreement for Up to $10 Million with Lincoln Park CapitalBy Nasdaq OMXSep 11, 2017, 1:30 PM UTC
BusinessBioLargo Achieves Important Milestones - Sales Increase by 176%By Nasdaq OMXAug 15, 2017, 2:45 PM UTC
